์ฃผ์š” ์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ

๊ท€ํ•˜์˜ ๋ธŒ๋ผ์šฐ์ €๊ฐ€ ์™„๋ฒฝํ•˜๊ฒŒ ์ง€์›๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ์˜ต์…˜์ด ์žˆ๋Š” ๊ฒฝ์šฐ ์ตœ์‹  ๋ฒ„์ „์œผ๋กœ ์—…๊ทธ๋ ˆ์ด๋“œํ•˜๊ฑฐ๋‚˜ Mozilla Firefox, Microsoft Edge, Google Chrome ๋˜๋Š” Safari 14 ์ด์ƒ์„ ์‚ฌ์šฉํ•˜์„ธ์š”. ๊ฐ€๋Šฅํ•˜์ง€ ์•Š๊ฑฐ๋‚˜ ์ง€์›์ด ํ•„์š”ํ•œ ๊ฒฝ์šฐ ํ”ผ๋“œ๋ฐฑ์„ ๋ณด๋‚ด์ฃผ์„ธ์š”.

์ด ์ƒˆ๋กœ์šด ๊ฒฝํ—˜์— ๋Œ€ํ•œ ๊ท€ํ•˜์˜ ์˜๊ฒฌ์— ๊ฐ์‚ฌ๋“œ๋ฆฝ๋‹ˆ๋‹ค.์˜๊ฒฌ์„ ๋ง์”€ํ•ด ์ฃผ์„ธ์š”์ƒˆ ํƒญ/์ฐฝ์—์„œ ์—ด๊ธฐ

Elsevier
์—˜์Šค๋น„์–ด์™€ ํ•จ๊ป˜ ์ถœํŒ

ํ”„๋กœํ•„

Eduard Puenteโ€‘Massaguer

Eduard Puente-Massaguer

Winner of the Host Country Early Career Researcher Award

Icahn School of Medicine at Mount Sinai, USA

Dr. Eduard Puenteโ€‘Massaguerโ€™s work focuses on mechanistic, translational vaccinology aimed at developing broadly protective vaccines against infectious diseases. His doctoral training at the Autonomous University of Barcelona centered on designing production platforms for nextโ€‘generation HIVโ€‘1 virusโ€‘like particle vaccines and implementing advanced singleโ€‘particle analytical methods. He subsequently joined Florian Krammerโ€™s laboratory at the Icahn School of Medicine at Mount Sinai under a Fundaciรณn Ramรณn Areces fellowship, where he advanced the development of universal influenza vaccine strategies using chimeric hemagglutinin and recombinant neuraminidase candidates that are now advancing into Phase I clinical trials. As an Assistant Professor, he leads the development of multivalent vaccines targeting respiratory pathogens and investigates the contribution of nonโ€‘hemagglutinationโ€‘inhibition immune mechanisms to broad and durable protection.